# NOPE37: Angiogenic Factors for Managing Term Preeclampsia

> **NCT07193680** · NA · RECRUITING · sponsor: **Hospital Universitari Vall d'Hebron Research Institute** · enrollment: 750 (estimated)

## Conditions studied

- Preeclampsia

## Interventions

- **OTHER:** Intervention arm: expectant management if sFlt-1/PlGF<38
- **OTHER:** Standard care: elective delivery at 37 weeks of gestation

## Key facts

- **NCT ID:** NCT07193680
- **Lead sponsor:** Hospital Universitari Vall d'Hebron Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-04
- **Primary completion:** 2027-12
- **Final completion:** 2028-04
- **Target enrollment:** 750 (ESTIMATED)
- **Last updated:** 2025-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07193680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07193680, "NOPE37: Angiogenic Factors for Managing Term Preeclampsia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07193680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*